Host apolipoprotein b messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus

Abstract

hA3G appears to be a cellular restrict factor against HCV and could be a potential target for drug discovery.